MMI Holdings' Exponential Ventures unit is the largest limited partner in a $16.5m fund closed by South Africa-based venture capital firm 4Di Capital.

Novo and Sofinnova Partners have co-led a series B round for Rgenix, which is preparing to enter two immunotherapies into clinical trials this autumn.

The two Australia universities come together to create a biomedical research enterprise called M2 Venture Catalyst with the backing of the state of Victoria.

Suneva has now raised more than $140m in debt and equity in total, and will use the capital to keep commercialising its skincare products.

HCA subsidiary Health Insight Capital co-led healthcare efficiency software developer Procured Health's latest round, raising its total funding to about $15m.

Investment firm Gilde Healthcare has closed its latest fund, which features Royal Philips as cornerstone investor and Johnson & Johnson as a limited partner.

Vivo Capital's Panda Fund has attracted commitments from Cathay Life Insurance and Taiwan Silicon Valley Technology Fund, as well as financial institutions and family offices.

Imperial Innovations exits its investment in Imperial College London spinout Alkion Biopharma, selling its shares to chemical company Evonik Industries.